Genmab A/S Stock

Genmab A/S Forward P/E

The Forward P/E Ratio of Genmab A/S (GMAB.CO) as of Jul 20, 2026 is 17.37. In the previous year, Forward P/E Ratio was 14.70 — a change of 18.14% (higher).

Forward P/E

17.37

YoY

18.14%

Last updated:

Forward P/E Ratio of Genmab A/S is 2026 17.37 . Forward P/E Ratio of Genmab A/S was 2025 14.70 . It decreases by 18.14% higher compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Forward P/E Ratio of Genmab A/S is 17.37 in 2026.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S